Article info

Download PDFPDF
Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor α soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3α and increases that of collagen in an in vitro model of rheumatoid synoviocyte activation
  1. Correspondence to:
    Professor P Miossec, Department of Immunology and Rheumatology, Hôf.pital E Herriot, 5 place d'Arsonval, 69437 Lyon Cedex 03, France;
    miossec{at}univ-lyon1.fr
View Full Text

Citation

Chevrel G, Garnero P, Miossec P
Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor α soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3α and increases that of collagen in an in vitro model of rheumatoid synoviocyte activation

Publication history

  • Accepted February 25, 2002
  • First published August 1, 2002.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.